DePuy Orthopaedics, Inc., part of the DePuy Synthes Companies of Johnson & Johnson, has acquired small bone fixation specialist BioMedical Enterprises, Inc. in a deal the details of which have not been announced.
Background
DePuy Synthes is the global market leader in the foot and ankle and hand and wrist markets for bone fixation in trauma. The company’s implants and instruments are also used for the surgical treatment of orthopaedic deformities and tumor diseases.
BioMedical Enterprises (BME) manufactures Nitinol (a so-called “memory metal”) orthopaedic implants for small bone fixation. The implants are used to treat bunions, hammertoes and other foot and ankle deformities, as well as hand and wrist deformities. J&J says the BME acquisition reinforces its focus on accelerating meaningful innovation and strengthening DePuy Synthes’ portfolio for elective extremity procedures – providing a more complete solution for foot and ankle and hand and wrist specialists.
BME is based in San Antonio, Texas and serves healthcare professionals in the United States and select markets throughout the world. Founded more than a decade ago, BME was one of the first U.S. manufacturers of Nitinol metal implants for musculoskeletal fixation and claims market leadership position in the use of memory metal implants for bone fixation. Nitinol is a nickel-titanium alloy that provides dynamic continuous active compression, which helps to promote healing after bone fixation. BME implants come ready-to-use on a sterilized, pre-loaded, fully disposable insertion tool.
Company comments
“BME’s technology is an excellent complement to our comprehensive portfolio of solutions that spans all of orthopaedics,” said Ciro Römer, Company Group Chairman, DePuy Synthes. “The BME portfolio will be integrated into our trauma platform, where we will be able to expand the availability of these solutions, increase the pace of innovation in this area, and reach more patients around the world. We look forward to welcoming the BME employees to DePuy Synthes.”
Source: DePuy Synthes Companies
published: May 11, 2016 in: DePuy, Extremity, Johnson & Johnson, Mergers and Acquisitions